DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,315,000 | -52.1% | 412,439 | -11.4% | 0.00% | -40.0% |
| Q2 2021 | $17,371,000 | +106.1% | 465,453 | +41.2% | 0.01% | +66.7% |
| Q1 2021 | $8,428,000 | +2.9% | 329,610 | -11.3% | 0.00% | 0.0% |
| Q4 2020 | $8,188,000 | +12.4% | 371,674 | -8.2% | 0.00% | 0.0% |
| Q3 2020 | $7,282,000 | -20.2% | 404,793 | +12.6% | 0.00% | -25.0% |
| Q2 2020 | $9,127,000 | +26.7% | 359,362 | -8.4% | 0.00% | 0.0% |
| Q1 2020 | $7,205,000 | -16.4% | 392,210 | +0.2% | 0.00% | +33.3% |
| Q4 2019 | $8,621,000 | +98.0% | 391,342 | +29.0% | 0.00% | +50.0% |
| Q3 2019 | $4,355,000 | +9.0% | 303,288 | +19.6% | 0.00% | 0.0% |
| Q2 2019 | $3,994,000 | – | 253,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,930,237 | $85,373,000 | 50.34% |
| RTW INVESTMENTS, LP | 5,029,462 | $48,082,000 | 4.58% |
| EcoR1 Capital, LLC | 4,764,447 | $45,548,000 | 4.57% |
| RA Capital Management | 3,933,489 | $37,604,000 | 2.88% |
| Cormorant Asset Management, LP | 3,600,954 | $34,425,000 | 2.57% |
| Omega Fund Management, LLC | 223,457 | $2,136,000 | 2.10% |
| Ghost Tree Capital, LLC | 950,000 | $9,082,000 | 1.84% |
| EMORY UNIVERSITY | 246,411 | $2,356,000 | 1.68% |
| Trustees of Princeton University | 114,286 | $1,093,000 | 1.63% |
| BRIDGER MANAGEMENT, LLC | 1,226,820 | $11,728,000 | 0.71% |